Cryo Cell International (CCEL) Proxy filing summary

Executive summary

• Annual Meeting scheduled for October 29, 2024, to elect four directors, ratify auditors, and hold a say-on-pay advisory vote.

• Record date for voting is September 20, 2024, with 8,062,159 shares outstanding.

• Proxy materials and annual report are available online for shareholder review.

Voting matters and shareholder proposals

• Shareholders will vote on electing four directors, ratifying Wipfli LLP as auditors, and approving a non-binding advisory resolution on executive compensation.

• No other shareholder proposals were submitted; any other business will be ruled out of order.

• Directors are elected by plurality; other proposals require a majority of votes cast.

• Broker non-votes and abstentions have no effect on outcomes for all proposals.

Board of directors and corporate governance

• Board consists of four members: David Portnoy, Mark Portnoy, Harold Berger, and Daniel Mizrahi.

• Berger and Mizrahi are considered independent directors.

• Committees include Audit, Compensation, Governance, and Nominating, all with independent members.

• Board and committees met regularly, with all directors attending at least 75% of meetings.

• Shareholders can communicate with the board via written correspondence.